Literature DB >> 10479451

An analysis of the early events when oligodendrocyte precursor cells are triggered to differentiate by thyroid hormone, retinoic acid, or PDGF withdrawal.

Y M Tokumoto1, B Durand, M C Raff.   

Abstract

Oligodendrocyte precursor cells withdraw from the cell cycle and terminally differentiate after a limited number of cell divisions. The timing of cell-cycle withdrawal and differentiation is controlled by an intrinsic timer, which consists of a timing component that measures elapsed time and an effector component that arrests the cell cycle and initiates differentiation. The effector component can be triggered by either thyroid hormone (TH) or retinoic acid (RA). In this study we investigate how TH and RA act to trigger differentiation. We show the following: (1) Synthetic retinoids that can inhibit AP-1 transcription factors but do not activate gene transcription cannot trigger the effector mechanism, suggesting that TH and RA do not act only by inhibiting AP-1 activity as previously suggested. (2) Both TH and RA induce a transcriptionally dependent antigenic change in purified precursor cells within 2-4 h. (3) Unexpectedly, even before they differentiate, the precursor cells express ceramide galactosyltransferase (CGT), the enzyme that catalyzes the final step in the synthesis of galactocerebroside, an early marker of oligodendrocyte differentiation. (4) Neither TH nor RA directly activates the transcription of the CGT gene, a number of immediate early genes, or the genes that encode any of the known cyclin-dependent kinase inhibitors. (5) The withdrawal of the mitogen platelet-derived growth factor (PDGF), but not TH or RA treatment, causes a rapid decrease in c-fos, NGFI-A/Krox-24, and cyclin D2 mRNA, even though all three treatments trigger cell-cycle arrest and differentiation. (6) PDGF withdrawal and TH treatment, but not RA treatment, induce an increase in cyclin D3 mRNA within 4 h. Thus, we have not found any early changes in gene expression that occur with all three treatments that trigger oligodendrocyte differentiation. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10479451     DOI: 10.1006/dbio.1999.9397

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  19 in total

1.  Adenosine: a neuron-glial transmitter promoting myelination in the CNS in response to action potentials.

Authors:  Beth Stevens; Stefania Porta; Laurel L Haak; Vittorio Gallo; R Douglas Fields
Journal:  Neuron       Date:  2002-12-05       Impact factor: 17.173

2.  Interaction of mTOR and Erk1/2 signaling to regulate oligodendrocyte differentiation.

Authors:  JinXiang Dai; Kathryn K Bercury; Wendy B Macklin
Journal:  Glia       Date:  2014-07-25       Impact factor: 7.452

3.  Suppressor of cytokine signaling 3 limits protection of leukemia inhibitory factor receptor signaling against central demyelination.

Authors:  Ben Emery; Holly S Cate; Mark Marriott; Tobias Merson; Michele D Binder; Cameron Snell; Pik Ying Soo; Simon Murray; Ben Croker; Jian-Guo Zhang; Warren S Alexander; Helen Cooper; Helmut Butzkueven; Trevor J Kilpatrick
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-08       Impact factor: 11.205

4.  E2F1 coregulates cell cycle genes and chromatin components during the transition of oligodendrocyte progenitors from proliferation to differentiation.

Authors:  Laura Magri; Victoria A Swiss; Beata Jablonska; Liang Lei; Xiomara Pedre; Martin Walsh; Weijia Zhang; Vittorio Gallo; Peter Canoll; Patrizia Casaccia
Journal:  J Neurosci       Date:  2014-01-22       Impact factor: 6.167

5.  Mathematical and experimental approaches to identify and predict the effects of chemotherapy on neuroglial precursors.

Authors:  Ollivier Hyrien; Jörg Dietrich; Mark Noble
Journal:  Cancer Res       Date:  2010-11-05       Impact factor: 12.701

Review 6.  Thyroid Hormone Signaling in Oligodendrocytes: from Extracellular Transport to Intracellular Signal.

Authors:  Jae Young Lee; Steven Petratos
Journal:  Mol Neurobiol       Date:  2016-07-18       Impact factor: 5.590

Review 7.  Mechanisms of cell-cell interaction in oligodendrogenesis and remyelination after stroke.

Authors:  Kanako Itoh; Takakuni Maki; Josephine Lok; Ken Arai
Journal:  Brain Res       Date:  2015-05-08       Impact factor: 3.252

8.  Two molecularly distinct intracellular pathways to oligodendrocyte differentiation: role of a p53 family protein.

Authors:  Y M Tokumoto; D G Tang; M C Raff
Journal:  EMBO J       Date:  2001-09-17       Impact factor: 11.598

9.  Cyclin-dependent kinase-2 controls oligodendrocyte progenitor cell cycle progression and is downregulated in adult oligodendrocyte progenitors.

Authors:  Shibeshih Belachew; Adan A Aguirre; Hang Wang; François Vautier; Xiaoqing Yuan; Stacie Anderson; Martha Kirby; Vittorio Gallo
Journal:  J Neurosci       Date:  2002-10-01       Impact factor: 6.167

10.  Activation of the mammalian target of rapamycin (mTOR) is essential for oligodendrocyte differentiation.

Authors:  William A Tyler; Nitish Gangoli; Pradeepa Gokina; Haesun A Kim; Matthew Covey; Steven W Levison; Teresa L Wood
Journal:  J Neurosci       Date:  2009-05-13       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.